Physician profile
Gregory L Alberts
NPI 1588666275
$807.15
in general payments reported to CMS, 2019-2025
15 companies · $71.68 in 2025
The $71.68 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $204 · 2021: $41.10 · 2022: $47.89 · 2023: $84.48 · 2024: $33.36 · 2025: $71.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.80 | 2019-2025 | Botox |
| Astellas Pharma US INC | $159.51 | 2019-2020 | |
| Travere Therapeutics, INC. | $77.73 | 2019-2021 | |
| Rochester Medical Corporation | $68.16 | 2020 | |
| Karl Storz Endoscopy-America | $58.69 | 2019-2020 | |
| Procept Biorobotics Corporation | $53.30 | 2025 | |
| Allergan, INC. | $48.62 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $38.34 | 2023 | Bard Urinary Drainage Bag |
| Pfizer INC. | $29.59 | 2019-2020 | |
| Coloplast Corp | $20.89 | 2022 | |
| Endo Pharmaceuticals INC. | $15.22 | 2023 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $14.87 | 2021 | |
| Medtronic, INC. | $13.56 | 2021 | |
| Srs Medical Systems, INC. | $13.26 | 2023 | Urocuff |
| Bard Access Systems, INC. | $12.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Alberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.